The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E) Meeting Abstract

  

Authors:	Armstrong, A. J.; Halabi, S.; Luo, J.; Nanus, D. M.; Giannakakou, P.; Szmulewitz, R. Z.; Danila, D. C.; Healy, P.; Anand, M.; Rothwell, C.; Silberstein, J.; Galletti, G.; Somarelli, J.; Gupta, S.; Gregory, S.; Scher, H. I.; Dittamore, R.; Tagawa, S. T.; Antonarakis, E. S.; George, D. J.
Abstract Title:	The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E)
Meeting Title:	54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	15 Suppl.
Meeting Dates:	2018 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-05-20
Start Page:	269s
Language:	English
ACCESSION:	WOS:000442916002117
DOI:	10.1200/JCO.2018.36.15_suppl.5004
PROVIDER:	wos
Notes:	Meeting Abstract: 5004 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169404